Micaela ROMAGNOLI, MD, PhD
Member of Staff
Interventional Pulmonology Unit
Policlinico S.Orsola-Malpighi
Azienda Ospedaliero-Universitaria di Bologna
Via Albertoni, 15, 40138 Bologna, ITALY
Tel +39 051 2142498
Email: [email protected]
Title and Contents
Page 1
Citizenship, Education and Training
Page 2
Certification and Licensure
Page 2
Work Experience
Page 2
Research Interests
Page 3
Grants
Page 3
Memberships in Professional Societies
Page 4
Editorial Positions
Page 4
Teaching
Page 4
Invited speaker at Seminars and Extramural Meetings
Page 4
Bibliography
Page 8
Micaela Romagnoli, MD, PhD
August 30th, 2015
1
Citizenship:
Italian
Education & Training
Education
09/1989 - 07/1994
09/1994 - 03/1998
09/1998 - 03/2003
University School of Medicine, Ferrara, Italy
Doctor of Medicine
University of Ferrara, Ferrara, Italy and University of Montpellier, France
Specialty in Respiratory Diseases
University of Parma, Parma, Italy
PhD in Respiratory Diseases
Training
09/1994 – 01/1996, and 04/1997 – 09/1998
Internship in Pulmonary Medicine: Pulmonology Unit and Research Centre on
Asthma and COPD, Department of Clinical and Experimental Medicine,
Section of Respiratory Disease, University of Ferrara, Italy.
02/1996 - 03/1997 Internship in Pulmonary Medicine: Clinique des Maladies Respiratoires, CHU
Arnaud de Villeneuve, University of Montpellier, France.
10/1998 - 2002
On the job, Pulmonology Unit and Research Centre on Asthma and COPD,
Department of Clinical and Experimental Medicine, Section of Respiratory
Disease, University of Ferrara, Italy.
Certification and Licensure
1989-1994
1994-1998
1998-2002
12/2013
01/2015
Medical Licensure, University of Ferrara, Italy
Board certified in Pulmonary Medicine, University of Ferrara, Italy
PhD in Respiratory Diseases, University of Parma, Italy
National certification for Assistant Professor, Italy
National certification for “Praticien Hospitalier”, Paris, France
Work Experience
May 2015 -
Member of staff, Interventional Pulmonology, S'Orsola-Malpighi hospital, University of
Bologna, Bologna, Italy
September 2014 - April 2015.
Member of staff, Pneumologie et Addictologie, Département Coeur-poumons. Centre
Hospitalier Universitaire (CHU) of Montpellier, Montpellier, France.
December 2005 - May 2015 (on leave without pay from September 2014 to April 2015)
Member of staff, Pulmonology, GB Morgagni - L. Pierantoni hospital (public hospital),
AUSL of Romagna, Forli ', Italy.
Micaela Romagnoli, MD, PhD
August 30th, 2015
2
January 2004 - December 2005
Member of staff, Pulmonology and Pulmonary Rehabilitation, Villa Pineta Ltd
(Accredited Private Hospital), Gaiato (Modena), University of Modena, Italy.
May 2003 - December 2003
Medical contractor, Pulmonology and Pulmonary Rehabilitation, Villa Pineta Ltd
(Accredited Private Hospital), Gaiato (Modena), University of Modena, Italy.
April 2001 - December 2002
Medical contractor, Respiratory Diseases Unit, Policlinico of Modena, University of
Modena and Reggio Emilia, Modena, Italy.
Research Interests
1. Lung cancer and mediastinal staging by EBUS-TBNA and EUS-FNA
2. Diffuse parenchymal lung diseases
3. Idiopathic NSIP (Non-Specific Interstitial Pneumonia), and connective tissue diseases-NSIP
correlated.
4. Drug-induced lung disease
5. Chronic obstructive pulmonary disease
6. Asthma and severe asthma
Grants
1997-1999: Multicenter ENFUMOSA study (cross-sectional European multicentre study)
Research Centre on Asthma and COPD, Department of Clinical and Experimental Medicine,
Section of Respiratory Disease, University of Ferrara, Ferrara, Italy
Co-Investigator
1999-2000 : European Respiratory Society grant.
Project : The role of leukotrienes in COPD excerbations. Pulmonology and Allergology unit, CHU
Hôpital Arnaud de Villeneuve, INSERM unit 454, Montpellier, France.
Principal investigator.
Multicenter BIOAIR study
Research Centre on Asthma and COPD, Department of Clinical and Experimental Medicine,
Section of Respiratory Disease, University of Ferrara, and Respiratory Diseases Unit, Policlinico of
Modena, University of Modena and Reggio Emilia, Modena, Italy.
Co-Investigator
2012-2014: CQAB149B2401 NOVARTIS
A randomized, double-blind, parallel-group, 26-week study comparing the efficacy and safety of
indacaterol (Onbrez breezhaler 150 mcg O.D.) with salmeterol/fluticasone propionate (Seretide
accuhaler 50 mcg/500 mcg B.I.D.) in patients with moderate chronic obstructive pulmonary disease.
Co-Investigator
Micaela Romagnoli, MD, PhD
August 30th, 2015
3
Memberships in Professional Societies
1999- European Respiratory Society
Editorial Positions
Reviewer
European Respiratory Journal
Sarcoidosis, Vasculitis and Diffuse Lung Disease
Pulmonary Pharmacology and Therapeutics
Respiratory Medicine
Respiration
Journal of Allergy and Clinical Immunology
Teaching
2010 -
Lecturer at the I and II level Master's in Interventional Pulmonology, University of
Florence, Florence, Italy
2012-2013.
Lecturer at the School of Specialization in Respiratory Diseases University University of
Ferrara, Italy.
Invited speaker at Seminars and Extramural Meetings
1. “Corso di aggiornamento su Asma e BPCO”, Ferrara, February 18th, 1998. “Linee-guida
Internazionali sulla diagnosi e trattamento di asma e BPCO”.
2. International Conference American Lung Association/American Thoracic Society, Chicago, IL,
USA, April 24-29th, 1998 (poster presentation).
3. “Corso di aggiornamento su Asma e BPCO”, Ferrara, October 29th, 1998. “Ruolo dei farmaci
inibitori della sintesi ed antagonisti recettoriali dei leucotrieni nel trattamento di asma e BPCO”.
4. International Conference American Lung Association/American Thoracic Society, San Diego,
CA, USA, April 23-28th 1999 (poster presentation).
5. VIII Corso di Aggiornamento in Pneumologia “L’Allergologia Respiratoria”. Napoli, May 18th
1999. “Recenti aggiornamenti delle linee guida internazionali sull’asma bronchiale”.
6. 9th Annual Congress of the European Respiratory Society, Madrid, Spain, October 9-13rd, 1999
(poster presentation).
7. International Conference American Lung Association/American Thoracic Society, Toronto,
Ontario, Canada, May 5-10th 2000 (poster presentation).
8. International Conference American Lung Association/American Thoracic Society, San
Francisco, California, USA, May 18-23rd 2001 (poster presentation).
Micaela Romagnoli, MD, PhD
August 30th, 2015
4
9. International Conference American Lung Association/American Thoracic Society, Atlanta,
Georgia, USA, May 17-22nd 2002.
10. Emerging Leaders in Respiratory Medicine. 1st part. Lund, Sweden, April 27-29, 2003.
11. 13st Annual Congress of the European Respiratory Society, Wien, September 2003 (poster
presentation).
12. Emerging Leaders in Respiratory Medicine. 2nd part. Chateau du Lac, Brussels, Belgium
October 29-31, 2003.
13. « Exercise-based assessment in respiratory medicine” – ERS School Course, Florence, January
29th-31st, 2004.
14. International Conference American Lung Association/American Thoracic Society, Orlando,
Florida, USA, May 21-26nd 2004.
15. 14st Annual Congress of the European Respiratory Society, Glasgow, Scotland, September 4-8,
2004 (poster presentation).
16. “Corso Residenziale sulle Pneumopatie Diffuse Infiltrative”, Forlì, February 4th-8th, 2008.
17. “Riunione monotematica multidisciplinare del Dipartimento Toracico 2008: “Polmoniti da
farmaci”, Forlì, April 1st, 2008.
18. “Corso Residenziale sulle Pneumopatie Diffuse Infiltrative”, Forlì, September 15th-19th, 2008.
19. “2009 International Guidelines on Rhinitis, Asthma, and COPD – Global Initiative ARIA,
GINA and GOLD/ATS/ERS”, Modena, March 1-4, 2009.
20. “2° Giornata Forlivese di Oncopneumologia”, Meldola (FC), April 16th-17th, 2009.
21. “La valutazione radiologica della resecabilità e la valutazione con imaging anatomico del
parametro N nel tumore del polmone”, Forlì, June 16th, 2009.
22. “1° Congresso Nazionale di Pneumologia Interventistica”, Firenze, June 19th-20th, 2009.
23. “European Respiratory Society Annual Congress 2009”, Wien, September 12-16th, 2009 (poster
presentation).
24. “Corso Residenziale sulle Pneumopatie Diffuse Infiltrative”, Forlì, October 19th-22nd 2009.
25. X Congresso UIP - XL Congresso Nazionale AIPO Milano, December 2nd-5th, 2009
26. “Corso Residenziale sulle Pneumopatie Diffuse Infiltrative”, Forlì, January 25th-27th, 2010.
27. “PneumoTrieste”, Trieste, May 10-12, 2010.
28. “American Thoracic Society International Meeting”, New Orleans, Louisiana, US, May 14th19th 2010 (poster presentation).
29. “Corso Residenziale sulle Pneumopatie Diffuse Infiltrative”, Forlì, June 14th-16th, 2010.
30. “Sarcoidosi e Dintorni”, Bassano del Grappa (VI), October 2nd, 2010.
31. “XI Congresso Nazionale della Pneumologia - UIP 2010, Milano, October 20th-23rd, 2010.
Micaela Romagnoli, MD, PhD
August 30th, 2015
5
32. “Corso Residenziale sulle Pneumopatie Diffuse Infiltrative”, Forlì, December 13th-15th, 2010.
33. Le Pneumopatie Interstiziali Diffuse - Polmonite Interstiziale Non-Specifica (NSIP) Forlì,
March 8-9, 2011.
34. “PneumoTrieste” - “Diffuse Parenchymal Lung Diseases” CLINICAL GRAND ROUND
Clinicians who present cases. Trieste, April 4th-6th, 2011.
35. Corsi “Executive” 2011 – Pneumologia Interventisitica, “La Pneumologia Interventistica oggi:
cosa sta cambiando?” - “Studio del mediastino dall’imaging all’EUS”. Firenze, November 1112, 2011.
36. Workshop Multidisciplinare In Medicina Toracica Firenze, December 16th-17th, 2011. Centro
Oncologico Fiorentino – Sesto Fiorentino (FI). “Nuove tecniche diagnostiche TBNA-EBUS e
EUS”.
37. “PneumoTrieste”, Trieste, Italy, March 5-7, 2012.
38. 1 Corso teorico pratico “LIVE CASES IN ONCOLOGIA TORACICA”, Ancona, Italy, April
12-14, 2012.
39. Interstiziopatie e HRCT. Corso multimediale e interattivo”, Bologna, Italy, May 5th, 2012.
40. Respiratory Critical Care Work Shadowing Evidence & Practice, Genova, Italy, May 10-12,
2012.
41. PROGETTO MESOTELIOMA PLEURICO VI° Corso di Aggiornamento Interdisciplinare,
Bologna, Italy, May 24th, 2012.
42. 3° Convegno Nazionale di Pneumologia Interventistica, Firenze, Italy, June 8th-9th, 2012.
43. Corso Executive di Pneumologia Interventistica, Bologna, Italy, November 9th-10th, 2012.
44. Corso AIPO residenziale “Fibrosi Polmonare idiopatica”, Forli’, Italy, February 19th-20 th, 2013.
45. 4o Master Universitario di IIo livello in Pneumologia Interventistica, Firenze, Italy, March 18th,
2013.
46. Corso AIPO residenziale “Pneumopatie diffuse infiltrative”, Forli’, Italy, March 20th-22nd, 2013.
47. “PneumoTrieste”, Trieste, Italy, April 8th-10th, 2013.
48. Corso AIPO residenziale “Pneumopatie diffuse infiltrative”, Forli’, Italy, April 10th-12, 2013
49. “Interstiziopatie e HRCT”, Bologna, Italy, May 16th-18th, 2013.
50. XIV Congresso Nazionale UIP (Unione Italiana per la Pneumologia), Corso Teorico-Pratico in
Pneumologia Interventistica - L’impiego degli ultrasuoni in Pneumologia Interventistica.
Verona, Italy, November 27th-30th, 2013.
51. “Malattie interstiziali diffuse”, Ravenna, Italy, April 9th-10th, 2014.
52. 5° Master di II livello in Pneumologia Interventistica a.a. 2013-2014. Firenze, Italy, May 5th
2014.
Micaela Romagnoli, MD, PhD
August 30th, 2015
6
53. 1° Convegno Pneumologia 2.0 – Interpretare il cambiamento nella gestione e terapia delle
malattie polmonari. Firenze, Italy, May 8th-10th, 2014.
54. CONGRESSO SEZIONE REGIONALE AIPO EMILIA – ROMAGNA, “Prospettive della
Pneumologia tra etica ed innovazione” - Applicazioni dell’EUS in Pneumologia Interventistica.
Reggio Emilia, Italy, June 12-13, 2014.
55. “European Respiratory Society Annual Congress 2014”, Post Graduate Course “Challenges
faced when diagnosing idiopathic interstitial lung disease” - Current challenges in diagnosing
and treating adults with interstitial lung disease. Munich, Germany, September 6th, 2014.
56. XV Congresso Nazionale della Pneumologia, Corso teorico-pratico di pneumologia
interventistica – Casi clinici. Genova, Italy, October 1st-3rd, 2014.
57. 2˚ Congresso Interdisciplinare sulla patologia polmonare nelle malattie reumatiche –
“PATTERN NSIP: idiopatico o diagnosi a posteriori”? Reggio Emilia, Italy, October 17th, 2014.
Micaela Romagnoli, MD, PhD
August 30th, 2015
7
Bibliography
Peer-Reviewed Journals and Publications
1.
Romagnoli M, Bourdin A. Transbronchial cryobiopsies in the evaluation of interstitial lung
diseases (ILDs): Time for a positioning in the diagnostic work-up approach? Respirology
2015;20(4):684.
2.
Kupczyk M1, ten Brinke A, Sterk PJ, Bel EH, Papi A, Chanez P, Nizankowska-Mogilnicka E,
Gjomarkaj M, Gaga M, Brusselle G, Dahlén B, Dahlén SE; BIOAIR investigators. Collaborators
(62):Weersink E, Papadopoulos N, Oikonomidou E, Zervas E, Contoli M, Pauwels RA, Joos GF,
de Rudder I, Schelfhout V, Richter K, Gerding D, Magnussen H, Siafakas NM, Tzortzaki E,
Samara K, Plataki M, Papadopouli E, Szczeklik A, Ziolkowska-Graca B, Kania A, GawlewiczMroczka A, Duplaga M, Figiel E, Rabe KF, Hiemstra PS, Gauw S, van Veen I, Kips JC,
Johnston SL, Mallia P, Campbell DA, Robinson DS, Kanniess F, Fabbri LM, Romagnoli M,
Vachier I, Devautour C, Meziane L, Vignola AM, Pace E, Profita M, Holgate ST, Howarth PH,
Wilson SJ, Hewitt L, Holoway J, Middelveld RJ, Damm K, Delin I, Eduards M, Ek A, Ekström
T, Gaber F, Gülich A, James A, Johansson LE, Karlsson O, Kumlin M, Martling I, Olsson M,
Skedinger M, Haque S. Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp
Allergy 2014;44(2):212-21. doi: 10.1111/cea.12179.
3.
Conti V, Grazia M, Romagnoli M, Poletti G, Cristino S, Ciliberti G, Piciucchi S, Mosconi G,
Poletti V. Lung injury associated with mTOR inhibitors (sirolimus and everolimus). Minerva
Urol Nefrol 2014;66(4):283-5.
4.
Ravaglia C, Tomassetti S, Gurioli C, Piciucchi S, Dubini A, Gurioli C, Casoni GL, Romagnoli
M, Carloni A, Tantalocco P, Buccioli M, Chilosi M, Poletti V. Features and outcome of familial
idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2014;18;31(1):28-36.
5.
Stella GM, Romagnoli M, Balestro E. Idiopathic pulmonary fibrosis clustering based on cilium
gene expression: profiling a new paradigm. Minerva Med 2014 Mar 11 [Epub ahead of print].
6.
Casoni GL, Tomassetti S, Cavazza A, Colby TV, Dubini A, Ryu JH, Carretta E, Tantalocco P,
Piciucchi S, Ravaglia C, Gurioli C, Romagnoli M, Gurioli C, Chilosi M, Poletti V.
Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One
2014 Feb 28;9(2):e86716. doi: 10.1371/journal.pone.0086716.
7.
Ulivi P, Casoni GL, Foschi G, Scarpi E, Tomassetti S, Romagnoli M, Ravaglia C, Mengozzi M,
Zoli W, Poletti V. MMP-7 and fcDNA Serum Levels in Early NSCLC and Idiopathic Interstitial
Pneumonia: Preliminary Study. Int J Mol Sci 2013;11;14(12):24097-112.
Micaela Romagnoli, MD, PhD
August 30th, 2015
8
8.
Kupczyk M, Haque S, Sterk PJ, Niżankowska-Mogilnicka E, Papi A, Bel EH, Chanez P, Dahlén
B, Gaga M, Gjomarkaj M, Howarth PH, Johnston SL, Joos GF, Kanniess F, Tzortzaki E, James
A, Middelveld RJ, Dahlén SE; BIOAIR investigators. Collaborators: Weersink E, Papadopoulos
N, Oikonomidou E, Zervas E, Contoli M, Pauwels RA, Brusselle G, de Rudder I, Schelfhout V,
Richter K, Gerding D, Magnussen H, Siafakas NM, Samara K, Plataki M, Papadopouli E,
Szczeklik A, Ziolkowska-Graca B, Kania A, Gawlewicz-Mroczka A, Duplaga M, Figiel E, Rabe
KF, Hiemstra PS, Gauw S, van Veen I, Kips JC, Mallia P, Campbell DA, Robinson DS, Fabbri
LM, Romagnoli M, Vachier I, Devautour C, Meziane L, Maurizio Vignola A, Pace E, Profita
M, Holgate ST, Wilson SJ, Hewitt L, Holoway J, Damm K, Delin I, Eduards M, Ek A, Ekström
T, Gülich A, Johansson LE, Karlsson O, Kumlin M, Martling I, Skedinger M. Detection of
exacerbations in asthma based on electronic diary data: results from the 1-year prospective
BIOAIR study. Thorax 2013;68(7):611-8.
9.
Ravaglia C, Gurioli C, Casoni GL, Romagnoli M, Tomassetti S, Gurioli C, Dubini A, Poletti V.
Sarcoid-like lesion is a frequent benign cause of lymphadenopathy in neoplastic patients. Eur
Respir J 2013;41(3):754-5.
10. Poletti V, Romagnoli M, Piciucchi S, Chilosi M. Current status of idiopathic nonspecific
interstitial pneumonia. Semin Respir Crit Care Med 2012;33(5):440-449.
11. Tomassetti S, Cavazza A, Colby TV, Ryu JH, Nanni O, Scarpi S, Tantalocco P, Buccioli M,
Dubini A, Piciucchi S, Ravaglia C, Gurioli C, Casoni GL, Gurioli C, Romagnoli M, Poletti V.
Transbronchial biopsy is useful in predicting UIP pattern. Respir Res 2012 29;13(1):96.
12. Ulivi P, Romagnoli M, Chiadini E, Casoni GL, Capelli L, Gurioli C, Zoli W, Saragoni L,
Dubini A, Tesei A, Amadori D, Poletti V. Assessment of EGFR and K-ras mutations in fixed
and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small
cell lung cancer patients. Intern J Oncol, 2012;41:147-152.
13. Margaritopoulos G, Romagnoli M, Poletti V, Siafakas N, Wells A, Antoniou K. Recent
advances in pathogenesis and clinical evaluation of pulmonary fibrosis. Eur
Respir Rev
2012;21(123):48-56.
14. Gurioli C, Ravaglia C, Romagnoli M, Casoni GL, Tomassetti S, Nanni O, Poletti V. EBUSTBNA in mediastinal/hilar lymphadenopathies and/or masses: an Italian case series. Clin Respir
J 2012;6:3-8.
15. Ravaglia C, Gurioli C, Tomassetti S, Casoni GL, Romagnoli M, Gurioli C, Agnoletti V, Poletti
V. Is medical thoracoscopy efficient in the management of multiloculated and organized thoracic
empyema? Respiration 2012;84:219-224.
Micaela Romagnoli, MD, PhD
August 30th, 2015
9
16. Ravaglia C, Gurioli C, Casoni G, Romagnoli M, Tomassetti S, Gurioli C, Corso RM, Poletti G,
Dubini A, Marinou A, Poletti V. Diagnostic role of rapid on-site cytologic examination (ROSE)
of broncho-alveolar lavage in ALI/ARDS. Pathologica 2012; 104(2):65-9.
17. Casoni GL, Cordeiro Jr CR, Tomassetti S, Romagnoli M, Chilosi M, Cancellieri A, Gurioli C,
Poletti V. (2012). The role of transbronchial biopsy in the diagnosis of diffuse parenchymal lung
diseases. Rev Port Pneumol 2012;18(2):57-60.
18. Romagnoli M, Nannini C, Piciucchi S, Girelli F, Gurioli C, Casoni GL, Ravaglia C, Tomassetti
S, Gurioli Ch, Gavelli G, Carloni A, Dubini A, Cantini F, Chilosi M, Poletti V. Idiopathic NSIP:
an Interstitial Lung Disease Associated with Autoimmune Disorders? Eur Respir J 2011;38:38491.
19. S. Piciucchi, M. Romagnoli, M. Chilosi, C. Bigliazzi, A. Dubini, B. Beomonte Zobel, G.
Gavelli, A. Carloni, V. Poletti. Prospective evaluation of drug-induced lung toxicity with highresolution CT and transbronchial biopsy. Radiol Med 2011;116(2):246-263.
20. Casoni GL, Chilosi M, Romagnoli M, Tomassetti S, Poletti V. Another “chance” for interferon
gamma 1b? Sarcoidosis Vasc Diffuse Lung Dis 2011;28(1):79-80.
21. Poletti V, Casoni G, Ravaglia C, Romagnoli M, Tomassetti S. Bronchoalveolar lavage.
Technical notes. Monaldi Arch Chest Dis 2011;75(1):42-3.
22. Romagnoli M, Poletti V. Diffuse infiltrative lung disease. Rassegna di Patologia dell’Apparato
Respiratorio 2011;26:69-70. ISSN: 0033-9563.
23. Tomassetti S, Carloni A, Chilosi M, Maff A, Ungari S, Sverzellati N, Gurioli C, Casoni G,
Romagnoli M, Ravaglia C, Poletti V (2011). Pulmonary features of Birt-Hogg-Dubé syndrome:
Cystic lesions and pulmonary histiocytoma. Respir Med 2011;105:768-774.
24. Marco Contoli, Simonetta Baraldo, Brunilda Marku, Paolo Casolari, John A. Marwick, Graziella
Turato, Micaela Romagnoli, Gaetano Caramori, Marina Saetta, Leonardo M Fabbri, Alberto
Papi. Fixed Airflow Obstruction due to Asthma or Chronic Obstructive Pulmonary Disease: 5year follow-up. J Allergy Clin Immunol 2010;125(4):830-7.
25. Romagnoli M, Casoni GL, Tomassetti S, Poletti V. (2010). Diffuse infiltrative lung diseases.
Rassegna di Patologia dell’Apparato Respiratorio 2010;25:72-73, ISSN: 0033-9563.
26. Casoni GL, Ulivi P, Mercatali L, Chilosi M, Tomassetti S, Romagnoli M, Ravaglia C, Gurioli
C, Gurioli C, Zoli W, Silvestrini R, Poletti V. Increased levels of free circulating DNA in
patients with idiopathic pulmonary fibrosis. Int J Biol Markers 2010;25:229-235.
27. Romagnoli M, Casoni GL, Tomassetti S, Poletti V. Year in Review: Pneumopatie infiltrative
diffuse. Rassegna di Patologia dell’Apparato Respiratorio 2010;25:72-73. ISSN: 0033-9563.
Micaela Romagnoli, MD, PhD
August 30th, 2015
10
28. Gurioli C, Casoni GL, Gurioli C, Tomassetti S, Romagnoli M, Ravaglia C, Poletti V.
Endobronchial ultrasound in Dieulafoy's disease of the bronchus: an additional application of
EBUS. Monaldi Arch Chest Dis. 2010;73:166-8.
29. Romagnoli M, Poletti V. Multifocal fibrosclerosis with lung, mediastinal, pancreatic and
retroperitoneal involvement in a 58-year-old man. Sarcoidosis Vasc Diffuse Lung Dis
2009;26:73-75.
30. Romagnoli M, Gurioli C, Casoni GL, Poletti V. Surgical lung biospy in the diagnosis of
idiopathic NSIP: do we really always need it in the initial approach? Am J Respir Crit Care Med
2009;179:1071-1072.
31. Romagnoli M, Poletti V. Update on non-specific interstitial pneumonia (NSIP): a pattern, a
clinical entity or different phenotypes? Surgical or bronchoscopic diagnosis? Recenti Prog Med.
2009;100(12):531-4.
32. Casoni G, Gurioli C, Romagnoli M, Poletti V. Diagnosis of pulmonary thromboembolism with
endobronchial ultrasound. Eur Respir Journal 2008;32(5):1416-1417.
33. Romagnoli M, Bigliazzi C, Casoni GL, Chilosi M, Carloni A, Dubini A, Gurioli Ch, Tomassetti
S, Gurioli C, Poletti V. The role of transbronchial lung biopsy for the diagnosis of diffuse druginduced lung disease: a case series of 44 patients. Sarcoidosis Vasc Diffuse Lung Dis
2008;25:36-46.
34. Romagnoli M, Tomassetti S, Balestro E, Calabro S, Dubini A, Asioli S, Poletti V.
Lymphoproliferative pulmonary diseases: From pulmonary lymphoid hyperplasia to lymphomas:
Part II. Malignant neoplastic pulmonary lymphoproliferative diseases Rassegna di Patologia
dell’Apparato Respiratorio 2008;23:75-87, ISSN: 0033-9563.
35. Balestro E, Romagnoli M, Poletti V, Calabro S. Lymphoproliferative pulmonary diseases: From
pulmonary
lymphoid
hyperplasia
to
lymphoms
Part
I.
Non-neoplastic
pulmonary
lymphoproliferative diseases (Review). Rassegna di Patologia dell’Apparato Respiratorio
2008;23:42-52, ISSN: 0033-9563.
36. Micaela Romagnoli, Gaetano Caramori, Fausto Braccioni, Franco Ravenna, Esther Barreiro,
Nikolaos Siafakas, Antonio M Vignola, Pascal Chanez, Leonardo M Fabbri, Alberto Papi, and
the ENFUMOSA Study Group. Near-Fatal Asthma phenotype in the ENFUMOSA Cohort. Clin
Exp Allergy 2007;37(4):552-7.
37. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM,
Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease
severe exacerbations. Am J Respir Crit Care Med 2006;15;173(10):1114-21.
Micaela Romagnoli, MD, PhD
August 30th, 2015
11
38. Romagnoli M, Dell'Orso D, Lorenzi C, Crisafulli E, Costi S, Lugli D, Clini EM. Repeated
Pulmonary Rehabilitation in Severe and Disabled COPD Patients. Respiration 2006;73:769-76.
39. Clini EM, Romagnoli M. Inpatient pulmonary rehabilitation: does it make sense? Chron Respir
Dis 2005;2(1):43-6.
40. Clini E, Romagnoli M. Early rehabilitation in COPD patients admitted for acute exacerbation.
Breathe 2005, vol. 1, ISSN: 1810-6838.
41. Rossi G, Florini F, Romagnoli M, Bellantone T, Lucic S, Lugli D, Clini E. Length and clinical
effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction. Chest
2005;127(1):105-9.
42. Romagnoli M, Luppi F, Corbetta L, Papi A, Fabbri LM. Management of fixed airflow limitation
caused by asthma or chronic obstructive pulmonary disease. Clinical & Experimental Allergy
Reviews 2004;4:205-211. ISSN: 1472-9725, doi: 10.1111/j.1472-9725.2004.00056.
43. Clini E, Costi S, Romagnoli M, Florini F. Rehabilitation of COPD patients: which training
modality. Monaldi Arch Chest Dis 2004;61(3):167-73.
44. Clini E, Romagnoli M. Self-management and healthcare utilisation in COPD patients. Breath
2004, 1, ISSN: 1810-6838.
45. Luppi F, Romagnoli M, Fabbri LM. The Global Initiative for Asthma guidelines: An update.
Eur Respir Rev 2004;13:57-61, ISSN: 0905-9180.
46. Romagnoli M, Fabbri LM. Chronic obstructive pulmonary disease: definition and classification
of severity. Ann Ist Super Sanita’ 2003;39(4):461-6.
47. Fabbri LM, Romagnoli M, Cossi S, Grassi V. Chronic obstructive pulmonary disease: brief
review. Ann Ital Med Int 2003;18(4):219-30.
48. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A,
Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction
due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med.
2003;167(3):418-24.
49. Caramori G, Romagnoli M, Casolari P, Bellettato C, Casoni G, Boschetto P, Chung KF, Barnes
PJ, Adcock IM, Ciaccia A, Fabbri LM, Papi A. Nuclear localisation of p65 in sputum
macrophages
but
not
in
sputum
neutrophils
during
COPD
exacerbations.
Thorax
2003;58(4):348-51.
50. Abraham B, Anto JM, Barreiro E, Bel EHD, Bonsignore G, Bousquet J, Castellsague J, Chanez
P, Cibella F, Cuttitta G, Dahlen B, Dahlen SE, Drews N, Djukanovic R, Fabbri LM, Folkerts G,
Gaga M, Gratziou C, Guerrera G, Holgate ST, Howarth PH, Johnston SL, Kanniess F, Kips JC,
Kerstjens HAM, Kumlin M, Magnussen H, Nijkamp FP, Papageorgiou N, Papi A, Postma DS,
Micaela Romagnoli, MD, PhD
August 30th, 2015
12
Pauwels RA, Rabe KF, Richter K, Roldaan AC, Romagnoli M, Roquet A, Sanjuas C, Siafakas
NM, Timens W, Tzanakis N, Vachier I, Vignola AM, Watson L, Yourgioti G (2003). The
ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic
severe asthma. Eur Respir J 2003;22:470-477.
51. Romagnoli M, Vachier I, Tarodo de la Fuente P, Meziane H, Chavis C, Bousquet J, Godard P,
Chanez P. Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J
2002;20(6):1370-7.
52. Romagnoli M, Fabbri LM. Mild asthma. N Engl J Med 2002;346(17):1335-6; author reply
1335-6.
53. Romagnoli M, A. Papi, F. Luppi, LM Fabbri. New therapeutic indications for Cys-LT1
antagonists: chronic obstructive pulmonary disease. Clinical & Experimental Allergy Reviews
2001;1:166-169, ISSN: 1472-9725, doi: 10.1046/j.1472-9725.2001.00033.
54. Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, Fabbri LM.
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in
chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162(5):1773-7.
55. Tarodo de la Fuente P, Romagnoli M, Carlsson L, Godard P, Bousquet J, Chanez P.
Eosinophilic inflammation assessed by induced sputum in corticosteroid-dependent asthma.
Respir Med 1999;93(3):183-9.
56. Romagnoli M, Vachier I, Vignola AM, Godard P, Bousquet J, Chanez P. Safety and cellular
assessment of bronchial brushing in airway diseases. Respir Med 1999;93(7):461-6.
57. De la Fuente PT, Romagnoli M, Godard P, Bousquet J, Chanez P. Safety of inducing sputum in
patients with asthma of varying severity. Am J Respir Crit Care Med 1998;157:1127-30.
58. Romagnoli M, Mourad G, Serre I, Senac JP, Paradis L, Godard P, Chanez P. Diffuse pulmonary
calcinosis without calcium metabolism abnormalities in a renal transplant recipient. Eur Respir J
1997;10(4):958-60.
59. Fugagnoli A, Castelletti ML, Caramori G, Romagnoli M, Fabbri LM, Ciaccia A. Subcutaneous
emphysema of the chest wall: a case with unusual presentation. Monaldi Arch Chest Dis
1997;52(5):447-9.
Non-Peer-Reviewed Publications
1. Fabbri L, Cremona G, Caramori G, Piattella M, Romagnoli M, Beghè B, Panella GL, Ciaccia A.
La scoperta dell’ossido nitrico endogeno ha aperto nuove prospettive terapeutiche nella patologia
polmonare dell’adulto? Rassegna di Patologia dell’Apparato Respiratorio 1996;11:554-576.
Micaela Romagnoli, MD, PhD
August 30th, 2015
13
2. Fugagnoli A, Castelletti ML, Caramori G, Romagnoli M, Fabbri LM, Ciaccia A. Subcutaneous
emphysema of the chest wall: a case with unusual presentation. Monaldi Archives for Chest
Disease 1997;52:447-449.
3. Cogo A, Romagnoli M, Ferrari M, Carati L, Ciaccia A. La N-acetilcisteina riduce la responsività
bronchiale all’aerosol ipotonico in rinitici non asmatici. Giorn It Mal Tor 1998;52,4,303-310.
4. Papi A, Corbetta L, Romagnoli M, Fabbri LM. La terapia dell’asma nelle più recenti linee guida.
Giorn It Allergol Immunol Clin (Ital J Allergy Clin Immunol)1998;8:46-49.
5. Micaela Romagnoli, Leonardo Fabbri. Se l'asma diventa una malattia di difficile trattamento
nell'adulto. In Ama Notizie, periodico dell'Associazione Malati Allergici della Regione Umbria
aderente a FEDERASMA. Anno 4, numero 1, febbraio-marzo 2001, stampa tipografia Grifo,
Perugia.
6. M. Romagnoli, A. Papi, F. Luppi, LM Fabbri. New therapeutic indications for Cys-LT1
antagonists: chronic obstructive pulmonary disease. Clinical and Experimental Allergy Reviews,
2001, Vol.1, N°2:166-169.
7. Micaela Romagnoli, Luca Richeldi, Leonardo Fabbri. Management of acute exacerbations of
COPD. Leukotriene Research & Clinical Review. 2002, Vol.2, N°3:1-4.
8. Fabrizio Luppi, Micaela Romagnoli, Leonardo Fabbri. Progetto Mondiale BPCO. Linee Guida
per la diagnosi, prevenzione e trattamento della BPCO. In: BPCO Dimensione SNAMID. 2002
Gennaio-Febbraio, pgg.16-30.
9. Micaela Romagnoli e Leonardo M Fabbri. Broncopneumopatia Cronica Ostruttiva: diagnosi e
classificazione di gravità. Annali dell’Istituto Superiore di Sanità. 2003; 39(4):461-466.
10. Leonardo Fabbri, Micaela Romagnoli, Stefania Cossi, Vittorio Grassi. Broncopneumopatia
Cronica Ostruttiva: una breve rassegna. Ann Ital Med Int 2003;18:219-230.
11. Romagnoli M, Fabbri LM. Chronic obstructive pulmonary disease: definition and classification
of severity. Ann Ist Super Sanità. 2003;39(4):461-6.
12. Micaela Romagnoli. La gestione ambulatoriale della Broncopneumopatia Cronica Ostruttiva.
Ed. Time Science. 2004.
13. Enrico Clini, Micaela Romagnoli. Asma bronchiale e Broncopneumopatia Cronica Ostruttiva
(BPCO): analogie e differenze nella genetica, nella clinica e nella terapia. Asma & Allergia, 2003.
14. Clini E, Romagnoli M. Self-management and healthcare utilisation in chronic obstructive
pulmonary disease patients. Eur Respir Top 2004; 10: (vol.3).
15. M Romagnoli, E Clini, LM Fabbri. Fixed airflow limitation caused by COPD or asthma: from
definition to management. Med Hypotheses Res 2004;1:101-110.
Micaela Romagnoli, MD, PhD
August 30th, 2015
14
16. Clini E, Costi S, Romagnoli M, Florini F. Rehabilitation of COPD patients: which training
modality. Monaldi Arch Chest Dis. 2004 Jul-Sep;61(3):167-73.
17. E. Clini, M Romagnoli. Self-management and healthcare utilisation in COPD patients. Breathe
2004; vol.1, No 1:52.
18. M Romagnoli, E Clini. A multidimensional grading system to predict outcome in COPD
patients. Breathe 2004;vol.1, No 2:152.
19. M Romagnoli, F Luppi, L Corbetta, A Papi, LM Fabbri. Management of fixed airflow limitation
caused by asthma or chronic obstructive pulmonary disease. Clin Exp All Rev 2004; 4:205-211.
20. E Clini, M Romagnoli. Early rehabilitation in COPD patients admitted for acute exacerbation.
Breathe, 2005;vol.1, No 3:245.
21. EM Clini, M Romagnoli. Inpatient pulmonary rehabilitation: does it make sense? Chronic
Respiratory Disease 2005; 2:43-46.
22. M Romagnoli, S.Tomassetti, E. Balestro, S. Calabro, A. Dubini, S. Asioli, V. Poletti. Malattie
Linfoproliferative del Polmone: dalle iperplasie polmonari linfoidi ai linfomi. Parte II: Malattie
linfoproliferative neoplastiche del polmone. Rassegna di Patologia dell'Apparato Respiratorio,
2008.
23. Micaela Romagnoli, Gian Luca Casoni, Sara Tomassetti, Venerino Poletti. Year in Review:
Pneumopatie infiltrative diffuse. Rassegna di Patologia dell’Apparato Respiratorio 2010;25:7273.
24. Venerino Poletti, Micaela Romagnoli, Gianluca Casoni, Caterina Bigliazzi, Sara Tomassetti,
Christian Gurioli, Androula Marinou, Gianni Marchi, Carlo Gurioli. Short report - La
ecoendoscopia transesofagea nelle lesioni mediastiniche - il messaggio per gli Pneumologi: “in
rebus dubis plurimum est audacia”. Rassegna di Patologia dell'Apparato Respiratorio
2009,24(3):120-123.
25. M Romagnoli, C Boissin, J Charriot, A Bourdin. Apport diagnostique de la cryobiopsie
pulmonaire transbronchique dans la fibrose pulmonaire idiopathique. La Lettre du Pneumologue
2015, vol.XVIII, n.3:180-182.
26. M Romagnoli, M Amalric, E Ahmed, E Verdanet, I Serre, A Bourdin. Cryobiopsies
pulmonaires transbronchiques dans les pneumopathies interstitielles diffuses. La Lettre du
Pneumologue 2015, in press.
Micaela Romagnoli, MD, PhD
August 30th, 2015
15
Chapters in International Books
1.
Romagnoli
M,
Papi
A,
Baraldo
S,
Fabbri
LM.
Difficult
asthma
and
chronic
obstructive
pulmonary disease (COPD): Similarities and Discrepancies. In: Holgate ST,
Boushey HA, Fabbri LM, Difficult asthma, London, Martin Dunitz 1999, Chapter 10: 163-181.
2.
M. Romagnoli, L. Richeldi and LM Fabbri. Clinical Assessment of Asthma and COPD:
Diagnosis. In Asthma and COPD. Eds Peter Barnes, Jeffrey Drazen, Stephen Rennard, Neil
Thomson. Academic Press, London, 2002;chap.43:447-455.
3.
Fabbri LM, Romagnoli M, Richeldi L, Olivieri D. Asthma versus chronic obstructive pulmonary
disease. In: Asthma. European Respiratory Monography. Chung F, Fabbri LM eds. Vol.8;
monograph 23, 2003:195-210.
4.
Pauwels P, Fabbri LM, Romagnoli M, Barnes PJ. Long-term management of persistent asthma in
adults. In: Asthma. European Respiratory Monography. Chung F, Fabbri LM eds. Vol.8;
monograph 23, 2003:376-395.
Chapters in National Books
1. Caramori G, Romagnoli M, LM Fabbri. Protocolli di trattamento farmacologico della
Broncopneumopatia cronica ostruttiva. In Broncopneumopatie Croniche Ostruttive. Rassegna di
Patologia dell’Apparato Respiratorio. A cura di A. Ciaccia, LM Fabbri. EDI-AIPO Scientifica,
Pisa 1998.
2. Romagnoli M, LM Fabbri. Linee guida internazionali per il trattamento dell’asma. In
L’Allergologia Respiratoria. Ariello Editore, Napoli 1999.
3. M. Romagnoli, A. Papi, LM Fabbri. Nuovi farmaci antiasmatici. In Asma Bronchiale. Collana
Monografica AIPO. EDIAIPO Scientifica, Pisa, 2000;pgg 275-293.
4. M. Romagnoli, A. Papi, LM Fabbri. Asma Grave. In Asma Bronchiale. Collana Monografica
AIPO. EDIAIPO Scientifica, Pisa, 2000;pgg 313-338.
5. Micaela Romagnoli e Leonardo M. Fabbri. Riacutizzazioni di broncopneumopatia cronica
ostruttiva (BPCO): alterazioni funzionali ed anatomia patologica. In: I Quaderni della BPCO. Il
volto della BPCO che cambia. Quaderno 4. C. Giuntini, LM Fabbri, V Grassi eds. 2002 UTET
Periodici, pgg-94-100.
Micaela Romagnoli, MD, PhD
August 30th, 2015
16
6. Fausto Braccioni, Micaela Romagnoli, Ippolito Guzzinati, Luca Richeldi, Alberto Papi. Asma
bronchiale e broncopneumopatia cronica ostruttiva. In: Focus on nitric oxide. Eds. Eugenio
Baraldi, Enrico Clini, George Cremona, Maurizio Vignola. Il Pensiero Scientifico Editore,
Roma, 2002; cap.8, pg:147-160.
August 30th, 2015
Signature:
Micaela Romagnoli, MD, PhD
August 30th, 2015
17